Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: Relationship with vascular access thrombosis and thromboembolic events

Human Antibodies

Volumn 9, Issue 2, 1999, Pages 125-131

  George, J ^a   Aron, A ^a   Levy, Y ^a   Gilburd, B ^a   Ben David, A ^a,b   Renaudineau, Y ^c   Zonana Nachach, A ^a   Youinou, P ^a,b   Harats, D ^c   Shoenfeld, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Laboratory of Immunology   (France)

Author keywords

Anti endothelial cell antibodies; Hemodialysis; Thromboembolic events

Indexed keywords

ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; MALONALDEHYDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; CROSSOVER PROCEDURE; DEEP VEIN THROMBOSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; LUNG INFARCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS; UREMIA; VASCULAR ACCESS;

EID: 6744236255     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-1999-9206     Document Type: Article

References (28)

1. Blank M, Cohen J, Toder V and Shonfeld Y, Induction of antiphospholipid syndrome in naive mice with lupus monoclonal and human polyclonal anti-cardiolipin antibodies, Proc Natl Acad Sci USA 88 (1991), 3069-3073.
2. Hughes, G.R.V., The antiphospholipid syndrome: ten years on. Lancet 342 (1993), 341.
3. Galli M, Comfurius MP, Maassen C, Hemker HC, De-Bates MH, van-Breda-Vriesman PJ, Barbui T, Zwaal RFA and Bevers EM, Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor, Lancet 335 (1990), 1544-1547.
4. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S and Koike T, Antibodies to (2GPI and clinical manifestations in patients with systemic lupus erythematosus, Arthritis Rheum 39 (1996), 1466-1474.
5. Garcia Martin F, De Arriba G, Carrascosa T, Moldenhauer F, Matin-Escobar E, Val J and Saiz F, Anticardiolipia antibodies and lupus anticoagulant in end stage renal disease, Nephrol Dial Transplant 6 (1991), 543-547.
6. Brunet P, Aillaud MF, San Marko M, Philip-Joet C, Dussol B, Bernard D, Juhan-Vague I and Berland Y, Antiphospholipids in hemodialysis patieats: Relationship between lupus anticoagulant and thrombosis, Kidney Int 48 (1995), 794-800.
7. Gronhagen-Riska C, Teppo AM, Helantera A, Honkanen E and Julkunen H, Raised concentration of antibodies to cardiolipin in patients receiving dialysis, Br Med J 300 (1990), 1696-1697.
8. Sitter T and Schiffl H, Anticardiolipin antibodies in patients on regular hemodialysis: An epiphenomenon? Nephron 64 (1993), 655-656.
9. Chew SL, Lins RL, Daelemans R, Zachee P, De clerck LS and Vermylen J, Are antiphospholipid antibodies clinically relevant in dialysis patients? Nephrol Dial Transplant 14 (1992), 1194-1198.
10. Meroni PL and Youinou PY, Endothelial cell autoantibodies, Autoantibodies, Elsevier Science B.V., 1996, pp. 245-251.
11. Carvalho D, Savage COS, Black CM and Pearson J, IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro, J Clin Invest 97 (1996), 111-119.
12. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Hughes GRV and Meroni PL, Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum 3 (1997), 551-561.
13. George J, Blank M, Levy Y, Meroni PL, Damianovich M, Tincani A and Shoenfeld Y, Differential effects of anti-(2GPI antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome, Circulation 97 (1998), 900-906.
14. McCrae KR, DeMichele A, Samuels P, Roth D, Kuo A, Meng QH, Rauch J and Cines DB, Detection of endothelial 'cell reactive immunolobulin in patients with anti-phospholipid antibodies, Br J Haematol 79 (1991), 595-606.
15. Direskeneli h, Ozgun S, Ozener C, Lawrence R, Erman M, Sarsmaz N and Akoglu E, Anti-lymhocyte, anti-moncyte and anti-endothelial cell antibodies in chronic haemodialysis patients, Nephrol Dial Transplant 7 (1992), 422-426.
16. Steinberg D, Parathasarathy S, Carew TE, Khoo JC and Witztum JL, Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity, N Engl J Med 320 (1989), 915-924.
17. Witztum JL, The oxidation hypothesis of atherosclerosis, Lancet 344 (1994), 793-795.
18. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Paliniski W and Witztum JL, Antibodies against oxidized LDL and the progression of carotid atherosclerosis, Lancet 339 (1992), 883-887.
19. Puurunen M, Manttari M, Manninen V et al., Antibody against oxidized LDL predicting myocardial infarction, Arch Intern Med 154 (1994), 2605-2609.
20. Amengual O, Atsumi T, Khamashta MA, Tinahones F and Hughes GRV, Autoantibodies against oxidized low-density lipoprotein in antiphospholipid synndrome, Br J Rheumtol 36 (1997), 964-968
21. Maggi E, Bellazzi R, Gazo A, Seccia M and Bellomo G, Autoantibodies against oxidatively modified LDL in uremic patients udergoing dialysis, Kidney Int 46 (1994), 869-876.
22. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D and Bellomo G, Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 45 (1994), 876-883.
23. Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, Kopolovic Y, Roth D, Barkai G, Meroni PL and Shoenfeld Y, Pathogenic role of antiendothelial cell antibodies (AECA) in vasculitis: an idiotypic experimental model, J Immunol 156 (1996), 4946-4951.
24. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M and Shoenfeld Y, Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3), J Clin Invest. 89 (1992), 1558-1563.
25. George, L, M Blank, B. Gilburd, M. Hojnik, B. Shenkman, I. Tamarin, D. Varon, E. Matsuura, T. Koike and Y. Shoenfeld, Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of β2-glycoprotein I, Int Immunol. 9 (1997), 913-921.
26. Sallam S, Wafa E, el-Gayar A, Sobh M and Salama O, Anticardiolipin antibodies in childeren on chronic heomodialysis, Nephrol Dial Transplant 9 (1994), 1292-1294.
27. Vaarala O, Alfthan G, Jauhiainen M and Leirisalo-Repo M Aho Knd Palosuo T, Crossreaction between antibodies to oxidized Low-density lipoprotein and to cardiolipin in systemic lupus erythematosus, Lancet (1993), 923-925.
28. Holvoet P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y and Collen D, Correlation between oxidized low density lipoproteins and von Willbrand factor in chronic renal failure, Thromb Haemost 76 (1996), 663-669.